Instant Quantification
of Genetic Modifications AAV Titer Edits AAV Structural Variants Knock-in Off-targets Single-bp Edits Genome Integrity Large Deletions
for Cell and Gene Therapies
With QUiCKR Kits, accelerate programs
in R&D, IND, and Process Development
5X faster while saving 70% on NGS costs
in R&D, IND, and Process Development
5X faster while saving 70% on NGS costs
120x Faster Results
Turnaround Time
5 Days
20 min
3x Throughput per Reader
Samples/day
400
1500
3x Reduction in Genomics Spend
Cost/Sample (with FTEs)
$50
$15
72x Reduction in Hands-On Time
Hands-on Time for 96 samples
12 Hours
10 min
NGS
QUiCKR
10,000+ samples analyzed to date
QUiCKR Technology
Example Results
Meet Our Team
We are passionate about accelerating broad access to life saving genetic medicines. Our mission is to engineer tools that test genetic modifications instantaneously. Imagine a world where genetic engineering can iterate as fast as software engineering.
Leadership
Charles Blanluet
CEO & Cofounder
Stanford Microfludics, Guardant
Prof. Juan Santiago
Scientific Cofounder
Stanford Microfludics, Purigen Biosystems
Jiawei Lee
CBO & Cofounder
UC Berkeley & UCSF, Sequoia
Henrik Sperber
CTO & Cofounder
CRISPR Therapeutics, Paratus Sciences
Kristian Laursen
CSO
Weill Cornell Medicine, Paratus Sciences
Advisors
Prof. Matthew Porteus
Scientific Advisor
Stanford Medicine, CRISPR Therapeutics
Hari Jayaram
Scientific Advisor
Verve Therapeutics, Editas Medicine, Arena BioWorks
Sepehr Kiani
Business Advisor
Fluent Biosciences, Bio-Rad
Paul Donohoue